Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
121
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Efficacy And Safety Of Adalimumab Biosimilar (Exemptia) In Moderate-To-Severe Steroid-Refractory Ulcerative Colitis Patients: Real-Life Outcomes In Resource-Constrained Setting At 24-Weeks Follow-Up

Alok ChandraDepartment of Gastroenterology, Base Hospital, New Delhi, India
,
Ravi KanthDepartment of Gastroenterology, Base Hospital, New Delhi, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1409-2503
ORCID Icon &
Sandeep TharejaDepartment of Gastroenterology, Base Hospital, New Delhi, India
Pages 191-200 | Published online: 25 Nov 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.